Thompson Davis & Co’s ORIX IX Stock Holding History

Thompson Davis & Co’s Portfolio IX Stock Details IX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-885	Closed	-$13K	–	1125
2017 Q1	$13K	Hold	885	–	–	0.02%	620
2016 Q4	$14K	Hold	885	–	–	0.02%	612
2016 Q3	$13K	Hold	885	–	–	0.02%	603
2016 Q2	$11K	Hold	885	–	–	0.02%	614
2016 Q1	$13K	Buy	+885	New	+$12K	0.02%	581

Other funds holding IX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

TAM

Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return

Renaissance Group Covington, Kentucky $2.39B AUM 27.81% 1-Year Est. Return

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

Thompson Davis & Co's IX Position: Q2 2017 in Review

Thompson Davis & Co sold out of ORIX (IX) in Q2 2017, closing a stake of 885 shares — an estimated $13K sold.

Thompson Davis & Co first reported a position in IX in Q1 2016 and held it in 5 quarters. The position peaked at $14K in Q4 2016. 124 funds tracked by Wall St. Rank hold IX as of Q2 2017.

Thompson Davis & Co reported no remaining ORIX position as of Q2 2017 after selling out during the quarter.
Thompson Davis & Co sold 885 ORIX shares in Q2 2017, an estimated $13K.
Thompson Davis & Co first reported a position in ORIX in Q1 2016 and held it in 5 quarters.
Thompson Davis & Co's ORIX position peaked at $14K in Q4 2016.
124 funds tracked by Wall St. Rank held ORIX as of Q2 2017.

Based on Thompson Davis & Co's 13F filing for Q2 2017, filed 10 Aug 2017.